Moleculin Biotech Inc. (MBRX)
0.97
-0.18 (-15.65%)
At close: Mar 04, 2025, 9:54 AM
Moleculin Biotech Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| PE Ratio | -0.85 | -1.11 | -5.64 | -3.14 | -2.82 | -2.27 | -3.52 | -5.71 | -60.61 |
| PEG Ratio | -0.18 | -0.01 | 0.07 | 0.14 | 0.10 | 0.17 | -0.11 | -0.03 | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 0.98 | 0.58 | 0.63 | 2.65 | 2.39 | 1.89 | 2.02 | 1.50 | -60.91 |
| P/FCF Ratio | -1.05 | -1.09 | -2.64 | -2.59 | -2.16 | -2.13 | -4.7 | -5.92 | -107.11 |
| P/OCF Ratio | -1.06 | -1.1 | -2.64 | -2.65 | -2.17 | -2.21 | -4.72 | -5.95 | -107.11 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.00 | 0.02 | 0.02 | n/a | n/a | 0.02 | -0.6 |
| Quick Ratio | 3.86 | 9.47 | 20.03 | 5.25 | 3.16 | 2.06 | 3.75 | 3.88 | 0.04 |
| Current Ratio | 3.86 | 9.46 | 20.02 | 5.89 | 3.78 | 2.06 | 3.75 | 3.88 | 0.04 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -89.86 | n/a |
| Return on Equity (ROE) | -1.14 | -0.53 | -0.11 | -0.84 | -0.85 | -0.83 | -0.57 | -0.26 | 1.00 |
| Return on Assets (ROA) | -0.78 | -0.48 | -0.11 | -0.52 | -0.52 | -0.61 | -0.5 | -0.24 | -26.64 |
| Return on Capital (ROIC) | -0.94 | -0.58 | -0.29 | -0.76 | -0.81 | -0.96 | -0.5 | -0.26 | 0.99 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |